MedTrace Logo

The INSPIRE-Lung Study

NCT05824273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 512

Last updated 2025-11-21

Study results available
· View outcomes & findings →

Summary

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Conditions

Interventions

BEHAVIORAL

LungTalk

LungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool.

BEHAVIORAL

Non-tailored intervention - Standard of practice

ACS Lung Screening Informational Video

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • Lisa Carter-Bawa, PhD · Hackensack Meridian Health

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-02
Primary Completion
2024-07-30
Completion
2024-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05824273 on ClinicalTrials.gov